Foster Dykema Cabot & Partners’s Zimmer Biomet ZBH Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.7K	Hold	425	–	–	﹤0.01%	198
2026 Q1	$38.5K	Hold	425	–	–	﹤0.01%	190
2025 Q4	$38.3K	Hold	425	–	–	﹤0.01%	207
2025 Q3	$42K	Hold	425	–	–	﹤0.01%	223
2025 Q2	$38.9K	Hold	425	–	–	﹤0.01%	212
2025 Q1	$48.2K	Hold	425	–	–	﹤0.01%	193
2024 Q4	$45K	Hold	425	–	–	﹤0.01%	208
2024 Q3	$46K	Hold	425	–	–	﹤0.01%	226
2024 Q2	$46.2K	Hold	425	–	–	﹤0.01%	180
2024 Q1	$56.2K	Hold	425	–	–	0.01%	173
2023 Q4	$51.8K	Buy	+425	New	+$47.4K	0.01%	151

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Foster Dykema Cabot & Partners's ZBH Position: Q2 2026 in Review

Foster Dykema Cabot & Partners held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 425 shares worth $36.7K. The position accounts for ﹤0.01% of the portfolio, ranked #198.

Foster Dykema Cabot & Partners first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $56.2K in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Foster Dykema Cabot & Partners held 425 shares of Zimmer Biomet worth $36.7K as of Q2 2026.
Foster Dykema Cabot & Partners left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #198 holding.
Foster Dykema Cabot & Partners first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
Foster Dykema Cabot & Partners's Zimmer Biomet position peaked at $56.2K in Q1 2024.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.